Ygot, Estrella L.

HRN: 24-50-56  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2025
CEFTRIAXONE 1G (VIAL)
08/28/2025
09/03/2025
IVTT
2g
Once A Day
Cholecystitis
Checking Initial Appropriateness 
08/28/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/28/2025
09/03/2025
IVTT
500mg
Every 8hrs
Cholecystitis
Checking Initial Appropriateness 
09/06/2025
CEFIXIME 200MG (CAP)
09/06/2025
09/12/2025
PO
200mg
BID
Massive Ascites
Checking Initial Appropriateness 
12/30/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/30/2025
01/06/2026
IVTT
3000mg
Q6h
Cellulitis
12/30/2025
CO-AMOXICLAV 625MG (TAB)
12/30/2025
01/06/2026
PO
500
Q12
Cellulitis
Checking Final Appropriateness 
12/30/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/30/2025
01/05/2026
IV
2.5
Q6
Cellulitis
Checking Final Appropriateness 
12/30/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/30/2025
01/05/2026
IV
1.5
Q6
Cellulitis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: